索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 引用因子
  • 宇宙IF
  • 西马戈
  • 乌尔里希的期刊目录
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • 期刊摘要索引目录
  • OCLC-WorldCat
  • 普罗奎斯特传票
  • 学者指导
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

The Role of Parathormone Measurement after Total Thyroidectomy: Short Review

Natalia Lucia Gómez*, Alejandro Yanzón de la Torre, Marcelo Fernando Figari

Hypocalcemia is a common complication after total thyroidectomy that results from inadvertent exeresis or devascularization of the parathyroids glands during surgery. Being able to predict patients at risk of postoperative hypocalcemia allows surgeons to prevent symptoms and adequate calcium supplementation. Stratification of patients at risk also prevents from unnecessary treatment and enables early hospital discharge in selected cases. Postoperative intact parathormone (iPTH) has been widely assessed as a reliable predictor of postoperative hypocalcemia; despite the variability that involves most protocols regarding timing and cut-off values, most of them agree that PTH has a high sensibility to predict patients in risk of postoperative hypocalcemia. The aim of this short review is to up-date knowledge in this issue. It seems that only one measurement is sensible enough to predict those patients in risk of hypocalcemia. Timing of dosage is still controversial but many authors agree that 4 to 6 hours is highly sensible. Besides, threshold levels are also a contentious issue but most publications consider that patients with normal PTH levels are unlikely to progress into risky hypocalcemia. Health costs could also be improved by using PTH assays, as patients could be discharged earlier and calcium supplementation optimized.